Gelsectan for irritable bowel syndrome with diarrhea
Part of Digestive system clinical trials.
This trial tests a supplement called Gelsectan to see if it reduces diarrhea and belly pain in people with diarrhea-predominant irritable bowel syndrome (IBS-D). It may help if you have loose, urgent stools more often than not.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with IBS-D for at least 6 months, with frequent belly pain and loose stools.
- In the past week, you had at least 4 days with loose or watery stools.
- Your average belly pain in the past week was a 3 or higher on a 0-10 scale.
- You are willing to stop certain diarrhea medications and probiotics 2-4 weeks before starting.
- You are not pregnant, breastfeeding, or planning pregnancy, and you agree to use effective birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if Gelsectan, a dietary supplement, can safely reduce diarrhea and abdominal pain in people with diarrhea-predominant irritable bowel syndrome (IBS-D). It may be a new option for managing your symptoms.
This study tests a daily supplement containing beneficial bacteria (synbiotic) and plant extracts to improve gut health and reduce symptoms of irritable bowel syndrome (IBS), such as bloating, gas, and changes in bowel habits. It lasts about 16 weeks and involves taking the supplement and providing blood and stool samples.
This study tests a dietary supplement called Enzymax DuoBiotics to see if it helps ease irritable bowel syndrome (IBS) symptoms like belly pain and irregular bowel habits. If you have IBS and are looking for a non-drug option, this may be a good fit.
This trial tests whether taking capsules containing freeze-dried healthy donor stool can improve symptoms of irritable bowel syndrome (IBS) that haven't gotten better with usual treatments. It aims to see if this approach is safe and helpful for people with moderate to severe IBS.
This trial tests a new treatment called SMT04 for people with irritable bowel syndrome (IBS), specifically the diarrhea or mixed types. It may help reduce symptoms like abdominal pain and changes in bowel habits.
This trial is testing if a dietary supplement can reduce symptoms of irritable bowel syndrome (IBS). You might qualify if you have been diagnosed with IBS, have moderate to severe symptoms, and are between 18 and 75 years old.
Hear when a new Irritable Bowel Syndrome (IBS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.